Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Christophe

Showing results (141-150 of 149) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 149 results.
Blood|December 7, 2010
Proteolytic antibodies activate factor IX in patients with acquired hemophiliaBharath Wootla, Olivier D Christophe, Ankit Mahendra, et al.
Blood|March 17, 2023
Efficacy of platelet-inspired hemostatic nanoparticles on bleeding in von Willebrand disease murine modelsStéphanie Roullet, Norman Luc, Julie Rayes, et al.
Cardiovascular Research|February 12, 2021
The VWF/LRP4/αVβ3-axis represents a novel pathway regulating proliferation of human vascular smooth muscle cellsJérémy Lagrange, Morel E Worou, Jean-Baptiste Michel, et al.
Research and Practice in Thrombosis and Haemostasis|June 23, 2022
Identification of von Willebrand factor D4 domain mutations in patients of Afro-Caribbean descent: In vitro characterizationMarie-Daniéla Dubois, Ivan Peyron, Olivier-Nicolas Pierre-Louis, et al.
Journal of Thrombosis and Haemostasis : JTH|June 4, 2023
Transplacental delivery of therapeutic proteins by engineered immunoglobulin G: a step toward perinatal replacement therapyAngelina Mimoun, Melissa Bou-Jaoudeh, Sandrine Delignat, et al.
JCI Insight|October 14, 2016
LIM kinase/cofilin dysregulation promotes macrothrombocytopenia in severe von Willebrand disease-type 2BAlexandre Kauskot, Sonia Poirault-Chassac, Frédéric Adam, et al.
Blood|December 23, 2022
A nanobody against the VWF A3 domain detects ADAMTS13-induced proteolysis in congenital and acquired VWDClaire Kizlik-Masson, Ivan Peyron, Stéphane Gangnard, et al.
Advances in Second Messenger and Phosphoprotein Research|January 1, 1997
The cAMP in thyroid: from the TSH receptor to mitogenesis and tumorigenesisN Uyttersprot, A Allgeier, M Baptist, et al.
Blood|February 22, 2013
Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variantJenny McIntosh, Peter J Lenting, Cecilia Rosales, et al.
Pageof 15

Showing results (141-150 of 149) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
Blood|December 7, 2010
Proteolytic antibodies activate factor IX in patients with acquired hemophiliaBharath Wootla, Olivier D Christophe, Ankit Mahendra, et al.
Blood|March 17, 2023
Efficacy of platelet-inspired hemostatic nanoparticles on bleeding in von Willebrand disease murine modelsStéphanie Roullet, Norman Luc, Julie Rayes, et al.
Cardiovascular Research|February 12, 2021
The VWF/LRP4/αVβ3-axis represents a novel pathway regulating proliferation of human vascular smooth muscle cellsJérémy Lagrange, Morel E Worou, Jean-Baptiste Michel, et al.
Research and Practice in Thrombosis and Haemostasis|June 23, 2022
Identification of von Willebrand factor D4 domain mutations in patients of Afro-Caribbean descent: In vitro characterizationMarie-Daniéla Dubois, Ivan Peyron, Olivier-Nicolas Pierre-Louis, et al.
Journal of Thrombosis and Haemostasis : JTH|June 4, 2023
Transplacental delivery of therapeutic proteins by engineered immunoglobulin G: a step toward perinatal replacement therapyAngelina Mimoun, Melissa Bou-Jaoudeh, Sandrine Delignat, et al.
JCI Insight|October 14, 2016
LIM kinase/cofilin dysregulation promotes macrothrombocytopenia in severe von Willebrand disease-type 2BAlexandre Kauskot, Sonia Poirault-Chassac, Frédéric Adam, et al.
Blood|December 23, 2022
A nanobody against the VWF A3 domain detects ADAMTS13-induced proteolysis in congenital and acquired VWDClaire Kizlik-Masson, Ivan Peyron, Stéphane Gangnard, et al.
Advances in Second Messenger and Phosphoprotein Research|January 1, 1997
The cAMP in thyroid: from the TSH receptor to mitogenesis and tumorigenesisN Uyttersprot, A Allgeier, M Baptist, et al.
Blood|February 22, 2013
Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variantJenny McIntosh, Peter J Lenting, Cecilia Rosales, et al.
Pageof 15